Overview
- Sequencing of plasma-derived cell-free RNA from ME/CFS patients and sedentary controls revealed alterations in gene expression linked to the illness.
- More than 700 transcripts showed significant differences between cases and controls, providing data for classifier development.
- Machine-learning models built on these transcripts achieved roughly 77% accuracy in distinguishing ME/CFS cases from controls.
- Cell-type deconvolution highlighted six altered immune cell signatures, with plasmacytoid dendritic cells most elevated.
- Led by Anne Gardella with co-senior Iwijn De Vlaminck and Maureen Hanson, the NIH- and WE&ME Foundation-funded study awaits broader validation before clinical use.